Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1099-2017Class II

Accu-Chek Connect Diabetes Management App

Roche Diabetes Care, Inc. / initiated 2016-12-20 / Terminated / root cause: software

Roche Diabetes Care, Inc. began a recall of Accu-Chek Connect Diabetes Management App on . FDA classified it as Class II and gives the reason as "iOS and Android: Under certain conditions the affected app versions may disregard historical bolus data potentially leading to an incorrect bolus insulin recommendation being provided to the user. iOS only: Pairing and...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1099-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Roche Diabetes Care, Inc.
Product
Accu-Chek Connect Diabetes Management App
Product code
NDC Calculator, Drug Dose
Reason for recall
iOS and Android: Under certain conditions the affected app versions may disregard historical bolus data potentially leading to an incorrect bolus insulin recommendation being provided to the user. iOS only: Pairing and using multiple meters with the Accu-Chek Connect app can under rare circumstances cause the bolus advisor to fail to offer a correction bolus recommendation within the eligible time window following a blood glucose measurement (10 15 minutes). Depending on the individual metabolic situation potentially incorrect bolus advice could lead to serious health consequences such as hypoglycemia. Both software issues may also cause the amount of active insulin displayed during the bolus calculation process to be incorrect and should not be used to manually calculate a bolus.
Root cause tag
software
FDA root cause
Software design
Action
Customers were notified via Google Play Store or the Apple App Store that an update to the Accu-Chek Connect App was available on December 20, 2016.. The description of the new version available in the app stores indicated that the new version resolved issues with the Bolus Advisor. It also includes direction to the Accu-Chek website. On December 21, 2016, information regarding the issues corrected with the new version was placed on the website. The information on the website was replaced on January 10, 2017, with the patient version of the Urgent Medical Device Correction (UMDC) which was sent on January 10, 2017, to US HCPs who have received prescription pads that would allow them to prescribe the bolus advice activation. If you have additional concerns, please contact the Accu-Chek Customer Service Center at 1- 800-858-8072. All other versions of the app as well as other Accu-Chek products using the bolus advice feature are not affected by this issue.
Quantity in commerce
27243
Distribution
Worldwide Distribution - Nationwide Distribution The Accu-Chek Connect App for iOS is distributed directly to end users via the Apple App Store. The Accu-Chek Connect App for Android is distributed directly to end users via the Google Play App Store.
Product codes and lots
Catalog number 07562462001 / GTIN number 00365702700000 Catalog number 07250452001 / GTIN number 00365702700017

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1099-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1099-2017Class IITerminatedVoluntary: Firm initiated